LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (NASDAQ: OMPI), the leader in skin health, today announced the launch of a new acne therapy – CLENZIderm M.D.™ Acne Therapeutic System. The new physician dispensed acne system boasts an advanced, patent-pending Soluzyl Technology™ that liquefies Benzoyl Peroxide (BPO) on contact, resulting in greater follicular penetration and rapid lesion reduction.
